About
Program Committee & Faculty
Continuing Education
Schedule/Program Agenda
Registration
Hotel & Travel
Scholarships
Abstracts
Ancillary Meetings
Exhibits and Sponsorship
Press
61st-Annual-Event-Banner-960x180

WHO SHOULD ATTEND?

The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.

AHS has dedicated over 60 years to leading and serving the headache community.

THE AMERICAN HEADACHE SOCIETY’S® ANNUAL SCIENTIFIC MEETING continues to be the premiere venue for the dissemination of the latest and most up-to-date research and scientific advances underlying the practice of Headache Medicine.

Register Now

SPECIAL NOTE FOR THE PHYSICALLY CHALLENGED

The American Headache Society® wishes to take steps to ensure that no individual with disability is excluded, denied services, segregated, or otherwise treated differently than other individuals because of the absence of auxiliary aids and services. If you need any auxiliary aids or services identified in the Americans with Disabilities Act, or any assistance in registering for this symposium, please contact AHS Meeting Manager, Heidi Jetter at 856-423-0043, write to her at AHS, 19 Mantua Road, Mt. Royal, NJ, 08061, or email AHSHQ@talley.com.

61st-Annual-Event-Banner-960x180

SCIENTIFIC PROGRAM COMMITTEE

Chair
Andrew C. Charles, MD, FAHS
UCLA
Los Angeles, CA

Members
Jessica Ailani, MD, FAHS
Medstar Georgetown University Hospital
Washington, DC

Rami Burstein, PhD
Harvard Medical School
Boston, MA

Amynah Pradhan, PhD
University of Illinois at Chicago
Chicago, IL

Ana Recober, MD, FAHS
Children’s Hospital of Philadelphia
Philadelphia, PA

Ann I. Scher, PhD, FAHS
Uniformed Services University of the Health Sciences
Bethesda, MD

Todd J. Schwedt, MD, MSCI, FAHS
Mayo Clinic Arizona
Phoenix, AZ

Elizabeth Seng, PhD
Yeshiva University/Albert Einstein College of Medicine
Bronx, NY

Christina L. Szperka, MD
Children’s Hospital of Philadelphia
Philadelphia, PA

Stewart J. Tepper, MD, FAHS
Geisel School of Medicine at Dartmouth
Lebanon, NH

61st-Annual-Event-Banner-960x180

EDUCATIONAL OBJECTIVES

At the conclusion of this meeting, attendees should be better able to:

  • Explain the current understanding of basic mechanisms of headache disorders
  • Identify alterations in homeostasis of the brain and body that are associated with migraine
  • Recognize emerging therapeutic strategies for the treatment of headache disorders.
  • Apply knowledge based on basic and clinical science of headache disorders to effective management of patients

EDUCATION MISSION STATEMENT

The provision of quality CME is a primary mission of the American Headache Society®. The Society’s educational objectives are to continue to improve the knowledge, skills, and professional performance of physicians, psychologists, and other health professionals in the care of patients with head, neck, and orofacial pain by:

  • Providing a forum for presentation of free scientific communication on research and clinical practice
  • Providing educational symposia
  • Improving education in medical schools and residency programs
  • Identifying and developing new educational initiatives
  • Supporting educational programs directed to people with head, neck, and orofacial pain
  • Maintaining strict adherence to ACCME guidelines

Developing education activities and tools that are designed and then evaluated for their role in improving the learners’ competence, performance, and the overall quality and safety of the care they give to individuals suffering from head, neck, and

CONTINUING MEDICAL EDUCATION

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. The American Headache Society® takes responsibility for the content, quality, and scientific integrity of this CME activity.

The American Headache Society® designates AMA PRA Category 1 credit(s)™ for the medical education activity, the 61st Annual Scientific Meeting, for a maximum of 19.50 credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

DISCLOSURE STATEMENT

All contributors who can affect American Headache Society CME content (including Leadership, Program Chairs, Program Committee Members, Moderators, Faculty, Speakers, Reviewers, Teachers, Authors, Medical Writers and Staff), in their respective roles, are required to disclose all relevant financial relationships with any commercial interest that could be viewed as a real or perceived conflict of interest. Contributors will also identify relevant financial relationships of their spouse, partner or immediate family. This policy is in effect to maintain adherence with the conflict of interest guidelines set by the Accreditation Council for Continuing Medical Education (ACCME) and the American Headache Society Ethics Committee.

Prior to the program, attendees will be made aware of the presence or absence of relevant financial relationships for any contributors who may affect the development, management, presentation or evaluation of the CME activity. The presence or absence of relevant financial relationships for any contributor who affects content are listed on the AHS website, mobile app (where applicable), presented verbally and in slide form. Individuals who refuse to disclose relevant financial relationships will be disqualified from being a contributor and cannot have control of, or responsibility for, the development, management presentation or evaluation of the CME activity.

Please click here to view financial disclosure information for this activity.

61st-Annual-Event-Banner-960x180

Preliminary Program

Click here to download a copy of the preliminary agenda.

For a complete list of poster presentations, please click here.

THURSDAY, JULY 11, 2019
6:30 am – 7:30 am Industry-supported Event

Phytomedicines in Migraine: Mechanisms Including Effects on CGRP, Review of Efficacy and Safety

Supported by Linpharma Inc. Session not certified for CME.

8:00 am – 10:00 am Pre-meeting Courses
8:00 am – 10:00 am PC1: The Anatomy of Headache and Orofacial Pain: An Interventional Based Cadaver Course

Presented at Thomas Jefferson University

Moderator: Paul G. Mathew, MD, DNBPAS, FAHS

8:00 am- 8:20 am Temporomandibular Disorders: Diagnosis and Management

Marcela Romero-Reyes, DDS, PhD, FAHS University of Maryland

8:20 am – 8:40 am Cranial Neuralgias: Nerve Blocks and Other Interventional Procedure

Paul G. Mathew, MD, DNBPAS, FAHS

Brigham and Women’s Hospital

Department of Neurology

Harvard Medical School

8:40 am – 9:20 am Expert Panel Discussion

Marcela Romero-Reyes, DDS, PhD, FAHS

University of Maryland

 

Paul G. Mathew, MD, DNBPAS, FAHS

Brigham and Women’s Hospital

Department of Neurology

Harvard Medical School

 

Rami Burstein, PhD

Beth Israel Deaconess Medical Center

 

Stephen D. Silberstein, MD, FAHS

Jefferson Headache Center

 

Alan Stiles, DMD

Thomas Jefferson University

9:20 am – 10:00 am Cadaver Dissection Session

Daniel Choi, DDS, MD

Thomas Jefferson University Hospital

8:00 am – 10:00 am PC2: Bridging the Gap Between Statistics and Applied Headache Research: A Collaborative Approach

Moderator: Megan Irby, MS, PhD

8:00 am – 8:10 am Welcome and Introduction

Megan B. Irby, MD

Wake Forest School of Medicine

8:10 am – 8:35 am Key Components to Designing (and Critiquing) Quantitative Headache Research Studies

James McGinley, PhD

Vector Psychometric Group, LLC

8:35 am – 9:00 am Fundamental Statistical Concepts for Better Understanding and Conducting Headache Research

Elizabeth Seng, PhD, FAHS

Albert Einstein College of Medicine

Yeshiva University

9:00 am – 9:20 am How to Choose and Effectively Work with a Statistical Consultant

RJ Wirth, PhD

Vector Psychometric Group, LLC

9:20 am – 9:40 am Insights on Research Design, Methods and Statistical Approaches

Richard B. Lipton, MD, FAHS

Albert Einstein College of Medicine

9:40 am – 10:00 am Panel Discussion and Questions
10:00 am – 10:30 am Coffee Break
10:30 am – 12:30 pm Pre-Meeting Courses
10:30 am – 12:30 pm PC3: Survival Skills in Practice: Coding, Practice Management and EMR Efficiencies

Moderator: Christina Szperka, MD, MSCE, FAHS

10:30 am – 10:35 am Introductions

Brad Klein, MD, MBA

Abington Neurological Associates

10:35 am – 11:00 am Basic Coding

Jessica Ailani, MD, FAHS

Medstar Georgetown University Hospital

11:00 am – 11:25 am Advanced Coding

Raissa Villaneuva, MD, MPH

University of Rochester Medical Center

11:25 am- 11:35 am Improving Your Efficiency with Your EMR

Christina Szperka, MD, MSCE, FAHS

Children’s Hospital of Philadelphia

11:35 am – 12:15 pm Practice Management Overview

Brian Grosberg, MD, FAHS

Ayer Neuroscience Institute, Hartford Healthcare

10:30 am – 12:30 pm Extinguishing Burnout: Finding Professional Fulfillment & Wellness in Life – The 2019 AHS Women’s Leadership Development Program

Moderator: Rashmi B. Halker Singh, MD, FAHS

10:30 am – 10:40 am Advocacy as an Antidote to Burnout

Amaal Starling, MD, FAHS

Mayo Clinic

10:40 am – 10:50 am Can Your Workplace Reflect Your Needs? What Is Possible at the Institutional Level for Improving Fulfillment

Rebecca Burch, MD, FAHS

Brigham and Women’s Hospital

Department of Neurology

Harvard Medical School

10:50 am – 11:00 am Setting Yourself up for Success with Healthy Expectations

Sara Sacco, MD, FAHS

Carolinas Headache Clinic

11:00 am – 11:10 am Building Work-Life Integration and Resilience

Rebecca Wells, MD, MPH, FAHS

Wake Forest University Baptist Medical Center

11:10 am -11:20 am Stepping in Vs. Stepping Back in Your Work and Life

Dawn Buse, PhD, FAHS

Albert Einstein College of Medicine

11:20 am – 11:30 am Organizing Your Time for Fulfillment and Success

Matthew S. Robbins, MD, FAHS

Weill Cornell Medical College

11:30 am – 12:30 pm Table Discussions

All Faculty

8:00 am – 12:30 pm                         Hot Topics in Basic Science Symposium

Moderators: Rami Burstein, PhD; Amynah Pradhan, PhD

8:00 am – 8:19 am Sex Differences in Meningeal Nociceptive Mechanisms

Greg Dussor, PhD

The University of Texas at Dallas

8:19 am – 8:38 am The Role of Delta Opioid Receptors in Trigeminovascular Pain

Amynah Pradhan, PhD

University of Chicago

8:38 am – 8:57 am Perivascular CGRP Actions in Migraine

Andrew F. Russo, PhD

Carver College of Medicine

8:57 am – 9:16 am Migraine/Pain and Opioid Mechanisms in our Brains. How Genetics, Attack Severity, and Treatment Impact Our Own Painkillers

Alexandre F. DaSilva, DDS, DMeDSc

University of Michigan

9:16 am– 9:35 am Efficacy, and Mechanisms of Action or CGRP Receptor Antagonists in Experimental Ischemic Stroke: Increased Cerebrovascular Event Risk?

Cenk Ayata, MD, PhD

Massachusetts General Hospital

9:35 am – 9:54 am Understanding Multisensory Hypersensitivity in Migraine

Mary Heinricher, PhD

Oregon Health and Sciences University

9:54 am – 10:13 am Neuronal PAC1 Receptors Mediate Delayed Activation and Sensitization of Trigeminocervical Neurons: Relevance to Migraine

Simon Akerman, PhD, FAHS

University of Maryland

10:15 am – 10:40 am Break
10:40 am – 11:00 am Inflammatory Role in Migraine

Aaron Schain, PhD

Beth Israel Deaconess Medical Center

11:00 am – 12:00 pm Data Blitz
11:00 am – 11:05 am DB01 – Single-cell RNA Sequencing of Migraine Associated Genes Across Neuronal, Glial and Neurovascular Cell Types in the Central and Peripheral Nervous System

Angeliki Vgontzas, MD

Graham Headache Center

11:05 am – 11:10 am DB02 – Central Mechanisms of Cortical Spreading Depression Inhibition by Vagus Nerve Stimulation

Andreia Morais, MS

Massachusetts General Hospital

11:10 am – 11:15 am DB03 – Cerebral and Systemic Angiopathy in Middle-aged People with Migraine

Ken Ikeda, MD, PhD

Toho University Omori Medical Center

11:15 am – 11:20 am DB04 – The Role of Cerebellar CGRP in Migraine-like Behavior

Mengya Wang, MS

University of Iowa

11:20 am – 11:25 am DB05 – Central Sites Controlling CGRP-induced Light-aversive Behavior

Levi Sowers, PhD

Va Center for the Prevention and Treatment of Visual Loss

11:25 am – 11:30 am DB06 – Noninvasive Vagus Nerve Stimulation Inhibits Trigeminal Nociception in Two Episodic Migraine Models by Enhancing Descending Pain Modulation

Paul Durham, PhD

Missouri State University

11:30 am – 11:35 am DB07 – Novel Receptor Activity Mapping of Methysergide and Its Metabolite, Methylergometrine, Provides a Mechanistic Rationale for Both the Clinically Observed Efficacy and Risk of Fibrosis in Patients with Migraine

Miguel Guzman, PhD

Xoc Phamaceuticals

11:35 am – 11:40 am DB08 – Cortical Spreading Depression Inhibition by Non-invasive Vagus Nerve Stimulation: Dose-response and Duration of Effect

Andreia Morais, MS

Massachusetts General Hospital

Harvard Medical School

11:40 am – 11:45 am DB09 – Early Life Stress-induced Increases in Cortical Spreading Depression Susceptibility and Anxiety Are Not Expressed in the Progeny of Stressed Male Rats

Stuart Collins, PhD

University of Toledo

11:45 am – 11:50 am DB10 – Early Life Stress Promotes Development of a Sensitized Trigeminal System and Gut Dysbiosis That Is More Severe in Females

Paul Durham, PhD

Missouri State University

11:50 am – 11:55 am DB11 – Noninvasive Vagus Nerve Stimulation and Morphine Transiently Inhibit Trigeminal Pain Signaling in a Chronic Migraine Model

Paul Durham, PhD

Missouri State University

11:55 am – 12:00 am DB12 – Diffuse Vasogenic Leakage of Gadolinium Contrast in Patients with Syndrome of Headache and Neurological Deficits with CSF Lymphocytosis (HANDL)

George Vilanilam, MD

Mayo Clinic

12:00 pm – 12:30 pm Panel Discussion
12:30 pm – 2:00 pm Industry-supported Event

A Migraine Preventive Therapy with Efficacy in Episodic and Chronic Migraine Patients

Supported by Novartis Pharmaceuticals. Session not certified for CME.

2:15 pm – 2:30 pm Welcome / Opening Remarks / AMF Update

Moderators: Kathleen B. Digre, MD, FAHS; Andrew C. Charles, MD, FAHS; David W. Dodick, MD, FAHS

2:30 pm – 3:00 pm Keynote Speaker

Moderator: Andrew C. Charles, MD, FAHS

2:30 pm – 2:35 pm Introduction
2:35 pm – 3:00 pm Concussion

Chris Nowinski

Concussion Legacy Foundation

3:00 pm – 4:00 pm Opening Plenary – Philadelphia Tribute

Moderator: Kathleen B. Digre, MD, FAHS

3:00 pm – 3:15 pm Headache Treatment from Anecdote to Evidenced Based Guidelines

Stephen D. Silberstein, MD, FAHS

Jefferson Headache Center

3:15 pm – 3:30 pm The Birth of Idiopathic Intracranial Hypertension without Papilledema

Shuu-Jiun Wang, MD, FAHS

Neurological Institute, Taipei Veterans General Hospital

3:30 pm – 3:45 pm Inventing the Future: How Headache Classification Research Reshapes Clinical Trials and Clinical Practice

Richard B. Lipton, MD, FAHS,

Albert Einstein College of Medicine

3:45 pm – 4:00 pm Blaming, Naming and Re-framing Migraine:  The Birth of Migraine Advocacy

William B. Young, Jr., MD, FAHS

Jefferson Headache Center

4:00 pm – 4:30 pm Special Interest Section Fair
4:30 pm – 5:15 pm AHS Membership Meeting
5:15 pm – 6:30 pm Exhibit and Poster Reception
6:30 pm – 7:30 pm Industry-supported Event

Redefining Expectations for Migraine Prevention

Supported by Alder BioPharmaceuticals, Inc. Session not certified for CME.

FRIDAY, JULY 12, 2019
6:30 am – 8:00 am Wellness for the Headache Provider

Moderator: Deena Kuruvilla, MD

6:30 am – 7:05 am Mindfulness Based Stress Reduction

Rebecca E. Wells, MD, MPH, FAHS

Wake Forest University Baptist Medical Center

7:05 am – 7:40 am Mindfulness Based Cognitive Therapy

Mia Minen, MD, MPH, FAHS

NYU Medical Center

7:40 am – 8:00 am The Evidence That Supports the Promotion of Physician Wellness

Deena Kuruvilla, MD

Yale University

6:30 am – 8:00 am Exhibits and Posters with Continental Breakfast
6:30 am – 8:00 am Exhibits and Posters

(Exhibit area closed 11:00 am – 12:45 pm)

8:00 am – 8:45 am Seymour Solomon Award Lecture

Moderator(s): Deborah I. Friedman, MD, MPH, FAHS; Seymour Solomon, MD, FAHS

Time’s Up: Headache Medicine in the #MeToo Era

Elizabeth W. Loder, MD, MPH, FAHS

John R. Graham Headache Center

8:45 am – 9:00 am Lifetime Achievement Award

Presented by Kathleen B. Digre, MD, FAHS

9:00 am – 9:15 am NIH Roadmap for Migraine Research Update

Michael Oshinsky, PhD

National Institutes of Health (NIH)

9:15 am – 9:30 am 4th Annual Migraine Moment Short Film Contest Winner Viewing

Presented by Amaal Starling, MD, FAHS

9:30 am – 10:00 am Early Career Award Lecture

Moderator: Todd J. Schwedt, MD, MSCI, FAHS

Does Mindfulness-based Cognitive Therapy for Migraine Reduce Migraine-related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trail

Elizabeth Seng, PhD, FAHS

Albert Einstein College of Medicine

Yeshiva University

10:00 am – 10:45 am Exhibits and Posters with Refreshments
10:45 am – 11:30 am Future of Headache Medicine

Moderator: Jessica Ailani, MD, FAHS

10:45 am – 10:53 am IHA Research Grant Presentation

Incidence, Consequences and Prevention of Postoperative, Pain-related Hospital Readmission in Migraineurs

Katharina Platzbecker, MD

Beth Israel Deaconess Medical Center

Harvard Medical School

10:53 am – 11:01 am IHA Research Grant Presentation

Photosensitivity, Tactile Hypersensitivity and Pain-related Facial Features as Objective Biomarkers of Chronic PTH

Anne-Sophie Wattiez, PhD

University of Iowa

11:01 am – 11:09 am Clinical Research Fellowship Award Update

Jill Rau, MD, PhD

Mayo Clinic

11:09 am – 11:17 am Future of Headache Medicine

Patterns of Diagnosis, Consultation, and Treatment of Migraine in the US: Results of the OVERCOME Study

Richard B. Lipton, MD

Albert Einstein College of Medicine

11:17 am – 11:25 am Future of Headache Medicine

Single-cell RNA Sequencing of Migraine Associated Genes Across Neuronal, Glial and Neurovascular Cell Types in the Central and Peripheral Nervous System

William Renthal, MD, PhD

Harvard Medical School

11:30 am – 1:00 pm Scientific Paper Presentations – Session 1

Moderator:  Elizabeth Seng, PhD, FAHS

11:30 am – 11:40 am OR01 – The Relationship Between Migraine and Risk of Cardiovascular Disease in Postmenopausal Women in the Observational Longitudinal Cohort of the Women’s Health Initiative Study (WHI)

Jelena Pavlovic, Md, PhD

Montefiore Headache Center

Albert Einstein College of Medicine

11:40 am – 11:50 am Or02 – Peroxynitrite Decomposition Catalysts Inhibit Acute Intracranial Dural-nociceptive Activation and Sensitisation of Central Trigeminovascular Neurons

Simon Akerman, PhD, FAHS

University of Maryland

11:50 am – 12:00 pm LBOR-01 – A Randomized Trial of Telemedicine for Migraine Management

Deborah I. Friedman, MD, MPH, FAHS

UT Southwestern Medical Center

12:00 pm – 12:10 pm OR04 – Acute and Preventive Treatment Patterns in Episodic Cluster Headache: Findings from the United States, United Kingdom and Germany

Jeffrey Scott Andrews, PharmD

Eli Lilly and Company

12:10 pm – 12:20 pm OR05 – Demographics, Headache Characteristics, and Other Factors Associated with Opioid Use in People with Migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study

Richard B. Lipton, MD, FAHS

Albert Einstein College of Medicine

12:20 pm – 12:30 pm OR06 – American Registry for Migraine Research: Methodology and Description of Initial Cohort

David Dodick, MD, FAHS

Mayo Clinic

12:30 pm – 12:40 pm OR07 – Noninvasive Vagus Nerve Stimulation Inhibits Trigeminal Nociception in Two Episodic Migraine Models by Enhancing Descending Pain Modulation

Paul Durham, PhD

Missouri State University

12:40 pm – 12:50 pm OR08 – One-Year Incidence of Migraine in the US Population: Results from the Migraine in America Symptoms and Treatment (MAST) Study

Richard B. Lipton, MD, FAHS

Albert Einstein College of Medicine

12:50 pm – 1:00 pm Frontiers in Headache Research Scholarship Presentation

Effectiveness of Outpatient Treatment of Headache at an Infusion Center

Hannah Johnson, MD

Boston Children’s Hospital

1:00 pm – 1:15 pm Scholarship Award Presentation
1:15 pm – 2:15 pm Exhibits and Poster Session/Lunch
1:15 pm – 2:15 pm Electronic Poster Presentation
2:15 pm – 3:00 pm Harold G. Wolff Award Lecture

Moderators: Todd J. Schwedt, MD, MSCI, FAHS; Thomas N. Ward, MD, FAHS

The Association Between Parental Migraine and Infant Colic: A Cross-sectional, Web-based, US Survey Study

Amy Gelfand, MD, FAHS

University of California, San Francisco

3:00 pm – 4:00 pm PLENARY II – Homeostasis/Hypothalamus

Moderator: Robert E. Shapiro, MD, PhD, FAHS

3:00 pm – 3:25 pm Pain and Hunger/Feeding

Nicholas Betley, PhD

University of Pennsylvania

3:25 pm – 3:50 pm Circadian and Seasonal Variation in Headache

Tim Houle, PhD

Massachusetts General Hospital

3:50 pm – 4:00 pm Q&A
5:00 pm – 6:00 pm Industry-supported Event

Nerivio Migra – A Novel Remote Electrical Neuromodulation (Ren) Device for the Acute Treatment of Migraine

Supported by Theranica Bio-Electronics LTD. Session not certified for CME.

5:00 pm – 6:30 pm Industry-supported Event

Migraine: Mining the Outer Reaches of Headache Science

Supported by Eli Lilly. Session is certified for CME.

SATURDAY, JULY 13, 2019
6:30 am – 8:00 am Exhibits and Posters with Continental Breakfast
6:30 am – 7:30 am Industry-supported Event

Patient Case Studies for Understanding Preventive Treatment of Migraine in Adults

Supported by Teva Pharmaceuticals. Session not certified for CME.

8:00 am – 10:00 am        Industry-submitted Abstracts*

*Session not eligible for CME

Moderator: Elizabeth Seng, PhD, FAHS

8:00 am – 8:10 am IOR01 – Orally Administered Atogepant Was Efficacious, Safe, and Tolerable for the Prevention of Migraine: Results from a Phase 2b/3 Study

David Dodick, MD, FAHS

Mayo Clinic

8:10 am – 8:20 am IOR02 – Ubrogepant Is Effective for the Acute Treatment of Migraine in Patients for Whom Triptans Are Ineffective

Andrew Blumenfeld, MD

Headache Center of Southern California

8:20 am – 8:30 am IOR03 – Phase 3 Placebo-Controlled Study of Galcanezumab in Patients with Chronic Cluster Headache: Results from 3-Month Double-Blind Treatment

Tina Oakes, PhD

Eli Lilly and Company

8:30 am – 8:40 am IOR04 – Non-invasive Vagus Nerve Stimulation for the Preventive Treatment of Episodic Migraine: The Multicenter, Double-blind, Randomized, Sham-controlled PREMIUM trial

Eric Liebler, BA

electroCore, Inc.

8:40 am – 8:50 am IOR05 – Efficacy, Safety, and Tolerability of Rimegepant 75 Mg Orally Dissolving Tablet for the Acute Treatment of Migraine: Results from a Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial, Study 303

Richard B. Lipton, MD, FAHS

Albert Einstein College of Medicine

8:50 am – 9:00 am IOR06 – Effects of Lasmiditan on Driving Performance: Results of 2 Randomized, Blinded, Crossover Simulated Driving Studies with Placebo and Active Controls

Eric Pearlman, MD, PhD

Eli Lilly & Company

9:00 am – 9:10 am IOR07 – Medication Overuse in a Post-hoc Analysis of Phase 3 Placebo-controlled Studies of Galcanezumab in the Prevention of Episodic and Chronic Migraine

Sheena Aurora, MD

Eli Lilly & Company

9:10 am – 9:20 am IOR08 – Clinically Meaningful Responses to Fremanezumab in Patients with Migraine and Documented Inadequate Response to 2-4 Classes of Migraine Preventive Medications in the Multicenter, Randomized, Placebo-controlled FOCUS Study

Egilius Spierings, MD, PhD

Medvadis Research Corporation

9:20 am – 9:30 am IOR09 – Results from the Chronic Migraine Epidemiology and Outcomes Study Demonstrate a High Level of Unmet Need for Migraine Treatment in People Who Discontinue Acute Prescription Migraine Medication

Susan Hutchinson, MD

Orange County Migraine & Headache Center

9:30 am – 9:40 am IOR10 – Sustained Efficacy and Long-term safety of Erenumab in Patients with Episodic Migraine: 4+ year results of a 5-year, Open-label Extension Study

Massoud Ashina, MD, PhD

University of Copenhagen

9:40 am – 9:50 am IOR11 – Incorporating Remote Electrical Neuromodulation (REN) into Usual Care Reduces Acute Migraine Medication Use

Michael J. Marmura, MD, FAHS

Thomas Jefferson University

9:50 am – 10:00 am LBIOR12 – First Non-invasive Combined Occipital & Trigeminal Nerve Stimulation Digital Therapeutics System for Treatment of Migraine: A Randomized, Sham-controlled, Double-blind Clinical Trial

Eran Schenker

George Washington University

10:00 am – 10:30 am Exhibits and Posters with Refreshments
10:30 am – 12:00 pm Scientific Paper Presentations – Session 2

Moderator: Amynah Pradhan, PhD

10:30 am – 10:40 am OR09 – Testing the Impact of Post-traumatic Headache on Headache Complexity in a Sample of Soldiers

Ann Scher, PhD,

Uniformed Services University

10:40 am – 10:50 am OR10 – Opioid Use Among People with Migraine: Results of the OVERCOME Study

Sait Ashina, MD

Beth Israel Deaconess Medical Center

Harvard Medical School

10:50 am – 11:00 am OR11 – Rates and Predictors of Using Opioids in the Emergency Department to Treat Migraine in Adolescents and Young Adults

Jennifer Bickel, MD

Children’s Mercy Hospital

11:00 am – 11:10 am OR12 – Cerebral and Systemic Angiopathy in Middle-aged People with Migraine

Ken Ikeda, MD, PhD

Toho University Omori Medical Center

11:10 am – 11:20 am OR13 – Characterization of the Effects of the Calcitonin Gene–Related Peptide (CGRP) Receptor Antagonists, Atogepant and Ubrogepant, on Isolated Human Coronary, Cerebral, and Middle Meningeal Arteries

Eloísa Rubio-Beltran, PhD

Erasmus University Medical Center

11:20 am – 11:30 am LBOR-02 – White Light Exposure and Risk of Headache Onset Among Patients with Episodic Migraine

Suzanne Bertisch, MD, MPH

Beth Israel Deaconess Medical Center

Harvard Medical School

11:30 am – 11:40 am LBOR-03 – Extracranial Injections of OnabotulinumtoxinA in Combination with Intravenous Injection of Atogepant Attenuates Activation and Sensitization of HT and WDR Neurons by CSD

Agustin Melo-Carrillo, MD, PhD

Beth Isreal Deaconess Medical Center

Harvard Medical School

11:40 am – 11:50 am LBOR-04 – Intake of Riboflavin (Vitamin B2) and the Occurrence of Migraine: A Cross-sectional Analysis of the National Health and Nutrition Examination Survey (NHANES) 2001 to 2004 Database

Margaret Slavin, PhD, RD

George Mason University

11:50 am – 12:00 pm Frontiers in Headache Research Scholarship Presentation

Pain Modulation Capabilities Relates to Headache Reduction After Cognitive Behavioral Therapy

Hadas Nahman-Averbuch, PhD

Cincinnati Children’s Hospital

12:00 pm – 1:00 pm Debate/Discussion

Moderator: David W. Dodick, MD, FAHS

What Does the Efficacy of CGRP Therapies Tell Us About Migraine Pathophysiology?

12:00 pm – 12:20 pm Peripheral Mechanisms of Migraine

Rami Burstein, PhD

Beth Israel Deaconess Medical Center

12:20 pm – 12:40 pm Central Mechanisms of Migraine

Peter J. Goadsby, MD, PhD, FAHS

University of California, San Francisco

12:40 pm – 1:00 pm Discussion
1:00 pm – 2:15 pm Exhibits and Poster Session
1:00 pm – 2:15 pm Electronic Poster Presentations
2:15 pm – 3:45 pm Scientific Paper Presentations – Session 3

Moderator: Andrew C. Charles, MD, FAHS

2:15 pm – 2:25 pm OR14 – Cutaneous Heat Pain and Light-Induced Pain Thresholds in Post-traumatic Headache Attributed to Mild Traumatic Brain Injury

Amaal Starling, MD, FAHS

Mayo Clinic

2:25 pm – 2:35 pm OR15 – Stigmatizing Attitudes About Migraine by People Without Migraine: Results of the OVERCOME Study

Robert Shapiro, MD, PhD, FAHS

Larner College of Medicine

2:35 pm – 2:45 pm OR16 – Pubertal Maturation and Its Association with Migraine Headache in Adolescent Girls

Vincent Martin, MD, FAHS

University of Cincinnati

2:45 pm – 2:55 pm OR17 – Migraine Care Across the Healthcare Landscape in the United States Among Those with ≥4 Migraine Headache Days Per Month: Results of the OVERCOME Study

Dawn Buse, PhD, FAHS

Albert Einstein College of Medicine

2:55 pm – 3:05 pm OR18 – Central Sites Controlling CGRP-induced Light-aversive Behavior

Levi Sowers, PhD

Va Center for the Prevention and Treatment of Visual Loss

3:05 pm – 3:15 pm OR19 – Headache Treatment Pattern and Co-morbid Health Burden Associated with Emergency Department and Urgent Care Use in People with Migraine: Survey Results from Migraine in America Symptoms and Treatment Study

Todd Schwedt, MD, MSCI, FAHS

Mayo Clinic

3:15 pm – 3:25 pm OR20 – Social Network Analysis of Young Adolescents with Migraine

Shuu-Jiun Wang, MD, FAHS

Taipei Veterans General Hospital

3:25 pm – 3:35 pm Clinical Research Fellowship Award Update

Julius Danesh, MD

Yale New Haven Hospital

3:35 pm – 3:45 pm Frontiers in Headache Research Scholarship Presentation

Enhancing Endocannabinoid Signaling During KCl-induced Cortical Spreading Depression to Reduce Headache Symptomology

Erika Liktor-Busa, PhD

University of Arizona

3:45 pm – 4:30 pm Exhibits and Posters with Refreshments
4:30 pm – 5:15 pm John R. Graham Award Lecture

Moderator: Paul B. Rizzoli, MD, FAHS, FAAN

Migraine Trigger Factors: Fact Vs. Fiction

Vincent Martin, MD, FAHS

University of Cincinnati

SUNDAY, JULY 14, 2019
7:00 am – 8:00 am Continental Breakfast
8:00 am – 10:00 am PLENARY III

Moderator: Christina L. Szperka, MD, MSCE, FAHS

8:00 am – 8:40 am Practical Clinical Issues Regarding New Acute and Preventive Headache Therapies

Matthew S. Robbins, MD, FAHS

Weill Cornell Medical College

8:40 am – 9:20 am PACAP as a Therapeutic Target

Messoud Ashina, MD, PhD, DMSc

University of Copenhagen

9:20 am – 10:00 am Cluster Headache – What’s New in Science and Practical Clinical Management

Stewart Tepper, MD, FAHS

Geisel School of Medicine at Dartmouth

 

61st-Annual-Event-Banner-960x180

AHS 61st Annual Scientific Meeting Registration Fees and Information

Online registration is closed. You may still register onsite should you wish to attend the conference.

Click here to access the registration brochure including the preliminary program agenda and paper registration form.

The following are the AHS Member and Non-member registration categories and associated fees for the 61st Annual Scientific Meeting.


Categories and Fees On-site
AHS Member (MD, DO, PhD, DDS, PharmD) $825.00
Non-member (MD, DO, PhD, DDS, PharmD) $1000.00
Associate Member (RN, NP, PA)
$550.00
Non-Member Associate (RN, NP, PA) $600.00
AHS Member Trainees $450.00
Non-member Trainees $450.00
Active Military Personnel $450.00
Industry Representative $1000.00

Pre-Meeting Course Registration Fees

On-Site
AHS Member $250.00
Non-member $600.00

 


Registration Information
Registration fees include admission to all Scientific sessions, Exhibit Hall, Continental Breakfasts, Refreshment Breaks and Receptions.


 Acceptable Forms of Payment

Checks are acceptable when registration is submitted by mail or completed onsite at the Annual Meeting. Checks must be made payable (in US dollars) to the American Headache Society and issued by a US correspondent bank. The registrant is responsible for any and all bank charges.

American Headache Society
61st Annual Scientific Meeting
19 Mantua Road
Mount Royal, NJ 08061

Credit cards may be used for all registrations. AHS accepts Visa, MasterCard, and American Express. AHS reserves the right to charge the correct amount, if different from your calculated total. Charges will appear on your statement as “AHS Registration.” Note: registrations paid by credit card may be faxed to 856-432-0082. Keep a copy of your fax transmittal confirmation for your record. If faxing, do not mail the original form, doing so may result in duplicate charges to your credit card.

Wire Transfers are accepted provided that the NET AMOUNT of the wire (after bank fees) is sufficient to cover all registration fees in US dollars. Please contact AHS Registration (856-423-0043 or ahshq@talley.com) for additional information on wire transfer payments.

Cash and Travelers Checks (US dollars only) are accepted for onsite registration at the Annual Meeting. Please do not send cash or travelers checks through the mail.

Group Discounts
AHS encourages you and your colleagues to take advantage of the discounted fees available when two or more from an organization (same location) register for the meeting. Registration for group discounts must be submitted together (by mail or fax) with acceptable form(s) of payment. A discount of $25.00 will be applied after the first registration is charged the full registration amount. The group discount is not available through online registration. Industry representatives are not eligible for the group discount. 

Letters of Invitation
If requested, the AHS will send a personal invitation for participation at the Annual Meeting. It should be understood that such an invitation is only to assist participants of the Annual Meeting to raise travel funds and to obtain a VISA and not a commitment on the part of the AHS to provide any financial support.

Cancellation Policy
If you must cancel your registration, all requests must be received in writing and postmarked no later than July 1, 2019. All fees paid will be refunded minus a $100.00 processing fee. There will be no refunds after the July 1, 2019 deadline. Cancellation requests can be mailed to AHS Registration, 19 Mantua Road, Mt. Royal, NJ 08061, emailed to ahshq@talley.com or faxed to 856-423-0082 Attention: AHS Registration Department.

61st-Annual-Event-Banner-960x180

Hotel Accommodations

Conference Headquarters Hotel (limited availability)
Philadelphia Marriott Downtown
1201 Market St.
Philadelphia, PA 19107
T: (215) 625-2900
Hotel Reservations: 888-236-2427

Online reservations can be secured by clicking HERE.

The Philadelphia Marriott Downtown hotel has been selected as the host hotel for the American Headache Society 61st Annual Scientific Meeting. Located on Market St. in the heart of Historic Center City Philadelphia, you can enjoy a workout in the fitness center, followed by a swim in the heated indoor pool. Circ and 13 Restaurant offer contemporary American dining, and the on-site Starbucks is the perfect spot to enjoy a cup of coffee before or after a busy day in downtown Philadelphia.

The hotel is connected via skywalk to Jefferson Train Station on the SEPTA Airport Line connecting to the Philadelphia International Airport. It is also connected by a skywalk to the Pennsylvania Convention Center.

The negotiated conference room rates are as follows:

Single/Double Occupancy Rate: $269.00
Additional person: $20.00

Overflow Hotel
The Notary Philadelphia Downtown
21 North Juniper St.
Philadelphia, PA 19107
T: (215) 564-1020
Hotel Reservations: 888-887-8130

Online reservations can be secured by clicking HERE.

Discover a piece of Philadelphia history! It’s a New Stay at The Notary Philadelphia Downtown, Autograph Collection hotel that opened after a $75 million restoration, recapturing the grandeur of its 1926 origins and placing it among premier downtown Philadelphia hotels. Unlike other downtown Philadelphia hotels, our 18-story, 498-room hotel is listed on the “National Register of Historic Places” and stands as a charming testament to time with unique architectural details. Catering to the group customer, our elegant historic hotel in Philadelphia, PA is ideally located in the “Heart of Center City” across from City Hall, 1 block to the Pennsylvania Convention Center and within walking distance of the Financial & Historic Districts, Avenue of the Arts and renowned restaurants and shopping.

The negotiated conference room rates are as follows:

Single/Double Occupancy Rate: $199.00

The above rates for the Philadelphia Marriott Downtown and The Notary Philadelphia Downtown do not include applicable state and local taxes, currently; City Levy of 0.75% of the guest-room rate and State and Local Occupancy Taxes of 15.5%.

Room reservations will be confirmed on a first come, first served basis until 5:00 pm local hotel time on Thursday, June 16, 2019 or until the block is sold out, whichever comes first. Reservation requests received after the cut-off date noted above will be based on availability at the hotel’s prevailing rate. All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card. Hotels will not hold any reservation unless secured by one of the above methods.

Please note reservations within the AHS block of rooms are for registered attendees ONLY. Reservations made by non-registrants will not receive the discounted rate.

Alternate Hotel (AHS is NOT contracted at this hotel and cannot guarantee availability)
Loews Hotel
1200 Market Street
Philadelphia, PA 19107
T: (215) 627-1200
Hotel Reservations: 855-690-0313

61st-Annual-Event-Banner-960x180

“Frontiers in Headache Research” Scholarship Award

The American Headache Society will award up to 10 recipients of the “Frontiers in Headache Research” Scholarship Award during the 61st Annual Scientific Meeting in Philadelphia from July 11 to July 14, 2019. Winners will receive complimentary meeting registration and are eligible to receive a stipend of up to $1,000 for reimbursement of expenses for hotel, travel and meals not provided during the Symposium. Winners will also receive a one-year AHS Trainee membership if not already a member of AHS, or a one-year extension of their existing AHS Trainee membership.

Winners will be selected based on the quality of his or her research proposal or study and the potential for the proposal, study or thesis to contribute to the advancement of the field of headache medicine. Applicants must be a Headache Medicine Fellow, Resident and or post-doctoral fellow who is in preparatory, active or completion phase of a basic or clinical research project that is related to headache or cranial nociception. Applicants must not have won an AHS scholarship within the past two years. Past winners within two years are not eligible to apply.

The top three selected will be required to present their proposal or results to attendees at the 2019 Annual Scientific Meeting on Friday, July 12, 2019, from 1:00 to 1:15 p.m. All other recipients will be required to submit a poster for display at the 2019 Annual Scientific Meeting.

The application period has closed.

Runnin’ for Research Advocacy Award

The American Headache Society will award up to two Runnin’ for Research Advocacy Awards for the 61st Annual Scientific Meeting, July 11-14, 2019 at the Pennsylvania Convention Center in Philadelphia, PA, or 2019 Scottsdale Headache Symposium, November 21-24, 2019 at the JW Marriott Camelback Inn in Phoenix, AZ.

Winners will receive complimentary registration for the meeting of their choice and are eligible to receive a stipend up to $2,000 for reimbursement of expenses for hotel, travel, and meals not provided during the meeting. Winners will also receive a one-year AHS Trainee membership if not already a member of AHS, or a one-year extension of their existing AHS Trainee membership.

Criteria for selection:

  • Any neurology resident may apply with preference given to applicants from cities involved in Runnin’ for Research events.

Applicant must:

  • Not have won an AHS scholarship within the past 2 years. Past winners within 2 years are not eligible to apply.
  • Reside in the United States or Canada.

The application period has closed.

61st-Annual-Event-Banner-960x180

Abstract submission is now closed; notifications regarding acceptance have been distributed at this time.

Poster Guidelines

Instructions for Poster Presentation
Poster Printing Service

Poster Set-up and Removal: Posters are to be placed on assigned board between 3:00 pm – 4:30 pm on Thursday, July 11.  Posters should not be removed before 5:00 pm on Saturday, July 13.   Any poster left after 5:00 pm on Saturday, July 13 may be discarded.

Poster Q & A Session: Poster presenters with an EVEN Poster number must be available at their poster between the hours of 1:15 pm – 2:15 pm on Friday, July 12. Poster presenters with an ODD poster number must be available between the hours of 1:00 pm – 2:15 pm on Saturday, July 13.

61st-Annual-Event-Banner-960x180

Ancillary Meeting Requests

All requests for ancillary meetings must be submitted no later than Friday, March 15, 2019. All requests will be given a final disposition no later than Monday, April 15, 2019. Upon approval from AHS, you will be provided with a contact name at the venue to assist in setting up your event.

Please complete all sections. Incomplete forms will NOT be processed. If your request is for multiple events, please submit a completed form for each event. You are responsible for all event costs, including but not limited to:

  • Room Rental – $500.00/room, per day. Invoice will be sent upon approval of request. Acceptable form of payments: Check, payable to AHS; Visa, MasterCard, American Express
  • Food and Beverage and Audio Visual
  • Attendee costs (airfare and applicable room nights)

Ancillary meetings may be held only during non-conference hours. Meetings are permitted on the following dates and times:

  • Monday, July 8, 2019 – All day
  • Tuesday, July 9, 2019 – All day
  • Wednesday, July 10, 2019 – After 7:30 pm
  • Thursday, July 11, 2019 – After 8:00 pm
  • Friday, July 12, 2019 – After 6:30 pm
  • Saturday, July 13, 2019 – After 5:00 pm
  • Sunday, July 14, 2019 – After 10:00 am

Please return completed forms to:

American Headache Society
19 Mantua Road
Mt. Royal, NJ 08061
T: 856-423-0043
F: 856-423-0082
E: ahshq@talley.com

61st-Annual-Event-Banner-960x180

Exhibit Hall Hours:

Thursday, July 11
5:15pm – 6:30pm

Friday, July 12
6:30am – 11:00am
11:00am – 12:45pm (Exhibits Closed)
12:45pm – 4:00pm

Saturday, July 13
6:30 am – 10:30 am
10:30am – 12:30pm (Exhibits Closed)
12:30pm – 4:30pm

Exhibit and Sponsorship Prospectus and Information

View the NEW Exhibitor / Sponsorship Portal, where you can rent your booth, select sponsorship opportunities, upload your logo and much more.

Click here to create your account

Once your account has been created, you will have access to up-to-date exhibit hall information including hall hours and ordering/shipping details. You will also be able to submit payments and manage your account settings.

The exhibit and sponsorship prospectus and exhibitor service kit are available in the Portal’s resource area should you need to review, or download below:

Exhibit and Sponsorship Prospectus
Exhibitor Service Kit

Exhibit Guidelines

Island Booth Restrictions: The maximum allowable height is 20ft (6.10m), including signage.

Poster Guidelines

Instructions for Poster Presentation
Poster Printing Service

Lead Retrieval

To purchase Lead Retrieval, please first register for the event and then click here.

Lead Retrieval instructions

CME Event

Please click the link below to download the CME Event Objectives and Guidelines. NOTE: A signature is required on this form and must be sent in with the application.

2019 CME Event Objectives and Guidelines

Non-CME Event

Please click the link below to download the Non-CME Event Policy and Guidelines. NOTE: A signature is required on this form and must be sent in with the application.

2019 Non-CME Event Policy and Guidelines

Industry-supported Event

Please click the link below to download the Industry-supported Event Request Form. NOTE: A signature is required on this form and must be sent in with the application.

2019 Industry-supported Event Request Form

 

Thank you to our 2019 exhibitors:

AAOP
Alder BioPharmaceuticals, Inc.
Allergan, Inc.
Allergan Medical Affairs
Alliance for Headache Disorders Advocacy (AHDA)
Alliance for Patient Access
Amgen/Novartis
Amneal Pharmaceuticals LLC
Assertio Therapeutics
Bausch Health
Biohaven Pharmaceuticals
CEFALY Technology
Coalition For Headache And Migraine Patients
Currax Pharmaceuticals, LLC
Dolor Technologies, LLC
electroCore, Inc.
eNeura, Inc.
Impel NeuroPharma
Lilly USA, LLC
Linpharma
N-1 Headache
National Headache Foundation
Neurology Reviews
NeurologyLive
Promius Pharma
Spherix Global Insights
Supernus Pharmaceuticals, Inc.
TerSera Therapeutics
Teva Pharmaceuticals
Theranica Bio-Electronics LTD
Tian Medical, LLC
U.S. Pain Foundation
Upsher-Smith Laboratories, LLC
Wolters Kluwer
Zosano Pharma

The American Headache Society gratefully acknowledges the support of the 61st Annual Scientific Meeting from our Industry Supporters

Allergan Logo

Allergan, Inc. is a $23 billion diversified global pharmaceutical company and a leader in a new industry model – Growth Pharma. The company is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team creating an unrivaled foundation for long-term growth.

Amgen and Novartis logos
Amgen, Inc. is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Lilly logo
Eli Lilly and Company – Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Teva logo
Teva Pharmaceuticals is committed to increasing access to high-quality healthcare for people across the globe, at every stage of life. We do this by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.



Alder Biopharmaceuticals logo
Alder BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms.

Biohaven Pharmaceuticals logo
Biohaven Pharmaceuticals is a clinical-stage biopharmaceutical company with proven leadership in industry and academic settings. Our portfolio is comprised of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, including rare disorders.

Supernus Pharmaceuticals logo
Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in produce development has been built over the past 25 years.



eNueura logo
Promius Pharma

Zosano Pharma logo


Bronze

Upsher-Smith logo

61st-Annual-Event-Banner-960x180

Welcome to the American Headache Society’s 61st Annual Scientific Meeting Press Room. Here you can find the latest news releases related to this scientific forum, as well as press guidelines for media professionals, exhibitors, presenters and satellite symposia organizers. If you are a media professional looking to request a press pass for the upcoming meeting, please check out the press guidelines posted below. If you have any questions or wish to speak to a member of the AHS or the American Migraine Foundation, please reach out to Alyssa Bleiberg at 212-845-5628 or alyssa.bleiberg@syneoshealth.com.

AHS Press Guidelines for Exhibitors and Presenters